Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Prognostic Accuracy of Different Biomarkers for Detection of Developmental Language Disorder in Children With Neonatal Encephalopathy

NCT07136636 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT07136636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07136636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Prognostic Accuracy of Different Biomarkers for Detection of Developmental Language Disorder in Children With Neonatal Encephalopathy
Lead sponsor
Semmelweis University
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2025
Completion date
December 31, 2026
Enrollment
93 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd - attention deficit disorder with hyperactivity, autism, hie - hypoxic - ischemic encephalopathy, intellectual developmental disorder, language delay, specific language impairment